14402 Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U.S. (OMB No. 0920–0338, exp. 4/ 

30/2011)—Extension—Office on 

Smoking and Health, National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC), Office on Smoking 

and Health (OSH) has the primary 

responsibility for the Department of 

Health and Human Services (HHS) 

smoking and health program. HHS’s 

overall goal is to reduce death and 

disability resulting from the use of 

smokeless tobacco products and other 

forms of tobacco use through programs 

of information, education and research. 

Since 1994, as required by the 

Comprehensive Smokeless Tobacco 

Education Act of 1986 (CSTHEA, 15 

U.S.C. 4401 et seq., Public Law 99–252), 

CDC has collected information about the 

ingredients used in smokeless tobacco 

products and their nicotine content. 

Respondents are commercial smokeless 

tobacco product manufacturers, 

packagers, or importers (or their 

representatives), who are required by 

the CSTHEA to submit ingredient 

reports to HHS on an annual basis. 

Respondents are not required to 

submit specific forms; however, they are 

required to meet reporting guidelines 

and to submit the ingredient report by 

chemical name and Chemical Abstract 

Service (CAS) Registration Number, 

consistent with accepted reporting 

practices for other companies currently 

required to report ingredients added to 

other consumer products. Typically, 

respondents submit a summary report to 

CDC with the ingredient information for 

multiple products, or a statement that 

there are no changes to their previously 

submitted ingredient report. 

Ingredient reports for new products 

are due at the time of first importation. 

Thereafter, ingredient reports are due 

annually on March 31. Information is 

submitted to OSH by mailing a written 

report on the respondent’s letterhead, by 

CD, three-inch floppy disk, or thumb 

drive. Electronic mail submissions are 

not accepted. 

Upon receipt and verification of the 

annual ingredient and nicotine data 

reports, OSH issues a Certificate of 

Compliance to the respondent. OSH also 

uses the information to report to the 

Congress (as deemed appropriate) 

discussing the health effects of these 

ingredients. 

In this Extension request, there are no 

changes to the estimated number of 

respondents, the estimated burden per 

response, or the information collection 

methods. There are no costs to 

respondents other than their time. The 

total estimated annualized burden hours 

are 18,843. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Smokeless Tobacco Manufacturers, Packagers, and Importers ................................................ 11 1 1,713 

Dated: March 10, 2011. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–6106 Filed 3–15–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2011–0002] 

Draft Action Plan—A Public Health 

Action Plan To Combat Antimicrobial 

Resistance 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (DHHS). 

ACTION: Notice of availability and 

request for public comment. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS) is publishing 

this notice requesting public comment 

on the draft A Public Health Action Plan 

to Combat Antimicrobial Resistance. 

HHS/CDC is publishing this notice on 

behalf of the HHS Interagency Task 

Force on Antimicrobial Resistance. The 

draft Action Plan and supporting 

documents can be found at http:// 

www.regulations.gov. 

DATES: Written comments must be 

received on or before April 15, 2011. 

Comments received after April 15, 2011 

will be considered to the fullest extent 

possible. 

ADDRESSES: Written comments may be 

submitted to the following address: 

Centers for Disease Control and 

Prevention, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Division of Healthcare Quality 

Promotion, Office of Antimicrobial 

Resistance, Attn: Antimicrobial 

Resistance Action Plan, Docket No. 

CDC–2011–0002, 1600 Clifton Rd., NE., 

Mailstop A–07, Atlanta, Georgia 30333. 

You may also submit written 

comments electronically to: http:// 

www.regulations.gov. All comments 

received will be posted publicly without 

change, including any personal or 

proprietary information provided. To 

download an electronic version of the 

plan, access http://www.regulations.gov. 

Written comments, identified by 

Docket No. CDC–2011–0002 will be 

available for public inspection Monday 

through Friday, except for legal 

holidays, from 9 a.m. until 5 p.m., 

Eastern Daylight Time, at 1600 Clifton 

Road, NE., Atlanta, Georgia 30333. 

Please call ahead to (404) 639–4000 and 

ask for a representative from the Office 

of Antimicrobial Resistance to schedule 

your visit. Comments may also be 

viewed at http://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Rachel Wolf, Centers for Disease Control 

and Prevention, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Division of Healthcare Quality 

Promotion, Office of Antimicrobial 

Resistance; 1600 Clifton Road, NE., 

Mailstop A–07, Atlanta, Georgia 30333, 

(404) 639–4000. 

SUPPLEMENTARY INFORMATION: The HHS 

Interagency Task Force on 

Antimicrobial Resistance (hereafter 

referred to as the Task Force) was 

created in 1999 to coordinate the 

activities of Federal agencies in 

addressing antimicrobial resistance (AR) 

in recognition of the increasing 

importance of AR as a public health 

threat. The Task Force is co-chaired by 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices 14403 

the Centers for Disease Control and 

Prevention (CDC), the Food and Drug 

Administration (FDA), and the National 

Institutes of Health (NIH). The Task 

Force also includes the Agency for 

Healthcare Research and Quality 

(AHRQ), the Centers for Medicare and 

Medicaid Services (CMS), the Health 

Resources and Services Administration 

(HRSA), the HHS Office of the Assistant 

Secretary for Preparedness and 

Response (HHS/ASPR), the Department 

of Agriculture (USDA), the Department 

of Defense (DoD), the Department of 

Veterans Affairs (VA), and the 

Environmental Protection Agency 

(EPA). 

In 2001, the Task Force developed an 

initial Action Plan, outlining specific 

issues, goals, and actions important for 

addressing the problem of AR. This 

document, entitled A Public Health 

Action Plan to Combat Antimicrobial 

Resistance, Part I: Domestic Issues, 

reflected a broad-based consensus of 

participating Federal agencies, which 

was reached with individual input from 

State and local health agencies, 

universities, professional societies, 

pharmaceutical companies, healthcare 

delivery organizations, agricultural 

producers, consumer groups, and other 

members of the public. Continued 

collaboration with these partners has 

been vital to achieving successful 

implementation of the Action Plan. 

This draft document, A Public Health 

Action Plan to Combat Antimicrobial 

Resistance, is a revision of the 2001 

interagency action plan. The revised 

Action Plan provides an updated 

blueprint for specific, coordinated 

Federal action to address emerging 

threats in AR. The document covers a 

broad spectrum of AR issues, addressing 

resistance in a wide range of pathogens 

(bacteria, viruses, fungi, and parasites) 

and settings (human medicine, 

veterinary medicine, agriculture, animal 

production, and others). 

The Action Plan includes action items 

organized into four focus areas: 

Surveillance, Prevention and Control, 

Research, and Product Development. 

The Action Plan contains specific action 

items, projects, and implementation 

steps. Wherever possible, action items 

are populated with specific projects or 

implementation steps to provide greater 

specificity for planned Federal 

activities. The action items, projects, 

and implementation steps do not 

represent an exhaustive list of activities. 

Dated: March 11, 2011. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–6100 Filed 3–15–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity: Comment Request 

Title: Personal Responsibility 

Education Program (PREP) MultiComponent Evaluation. 

OMB No.: New collection. 

Description: The Family Youth 

Services Bureau (HHS/ACF/ACYF/ 

FYSB) and the Office of Planning 

Research and Evaluation (HHS/ACF/ 

OPRE) in the Administration for 

Children and Families (ACF) are 

proposing three data collection 

activities to be undertaken for the 

Personal Responsibility Education 

Program (PREP) Multi-Component 

Evaluation. 

The impact study included in the 

PREP Multi-Component Evaluation is a 

random assignment evaluation which 

will expand available evidence on 

whether the replication of evidencebased effective programs, or the 

substantial incorporation of elements of 

these programs, funded as part of the 

Personal Responsibility Education 

Program, are effective at delaying sexual 

activity, increasing condom or 

contraceptive use for sexually active 

youth, or reducing pregnancy among 

youth. The evaluation will document 

and test a range of pregnancy prevention 

approaches in up to five program sites. 

The findings from the evaluation will be 

of interest to the general public, to 

policy-makers, and to organizations 

interested in teen pregnancy prevention. 

This Federal Register Notice is to 

notify the public regarding Data 

Collection for the Baseline, Field 

Collection, and In-Depth 

Implementation Components of the 

Impact and In-Depth Implementation 

Evaluation of the Personal 

Responsibility Education Program 

(PREP) Multi-Component Evaluation. 

Field Collection: The field collection 

activity involves the collection of 

information from observations of 

program activities and interviews with a 

range of experts and persons involved 

with programs about various aspects of 

existing prevention programs and topics 

the experts view as important to address 

through evaluation. These data will be 

used to help enhance decisions about 

the types of programs to be evaluated in 

the studies. 

In-Depth Implementation: The 

implementation data collection activity 

as part of the in-depth implementation 

portion of the PREP Multi-Component 

Evaluation involves the collection of 

information from program records and 

site visits at two to three points in the 

program implementation period. 

Understanding the programs, 

documenting their implementation and 

context, and assessing fidelity of 

implementation will allow for 

description of each implemented 

program and the treatment-control 

contrast evaluated in each site. It will 

also help in interpreting impact 

findings, differences in impacts across 

programs, and differences in impacts 

across locations or population 

subgroups. 

Baseline: The baseline data collection 

activity will present respondents with 

carefully selected questions about 

demographics and risk and protective 

factors related to teen pregnancy. Also 

proposed is a collection of school 

records, performance, and program 

participation for the youth. Information 

from this data collection will be used to 

perform meaningful analysis to 

determine significant program effects. 

Respondents: 

Field Clearance: Researchers; Policy 

Experts; State Level Coordinators; 

Program Directors; Program Staff; 

Program Participants; School 

Administrators. 

In-Depth Implementation: General 

Staff; Community Members; Frontline 

Staff; Participating Youth; and Control 

Group Schools. 

Baseline: Study participants (i.e., 

adolescents, and schools and 

organizations responsible for 

administrative data); Schools and 

Organizations. 


jlentini on DSKJ8SOYB1PROD with NOTICES